AI-Powered Innovation using Forced Cough Vocalization
RAIsonance, Inc., the leader in artificial intelligence powered analysis of Forced Cough Vocalization (FCV), announces expansion into new wellness product categories. This proprietary technology focuses on FCV signature analysis, which uses these intentional coughs as a rich source of biometric and biomarker data to detect changes to an individual’s cough sound signatures, tracking a key respiratory wellness metric.
RAIsonance has incorporated this FCV Wellness technology into 3 new product lines launching over the next 60 days:
- FCV Sentinel is a threat-agnostic early warning system that detects changes that may be the result of a pathogen, chemical agent, or environmental toxin experienced by the user.
- MyAdvocate is designed specifically to assist individuals for ongoing conditions that users wish to track such as Long COVID, or to track improvement such as once a person has quit smoking or vaping.
- Biometric SoundPass operates like a “check engine” light, alerting the user that an out-of-range FCV change has been detected and provides a “first alert” signal.
Each of the RAIsonance product lines use a mobile app interface to collect a series of intentional coughs which are processed in their cloud-based FCV analysis system. Guided by the app, these initial coughs are collected over a prescribed period of time to build a complex, multi-dimensional FCV profile or baseline for the user. Once established, the user can cough into the mobile app again anytime, and the powerful Artificial Intelligence (AI) rapidly compares that user’s new cough to their previously established baseline. In about 2 minutes, the results are available in the app, designed to track even the smallest changes.
Learn more about RAIsonance’s line of FCV Signature Analysis products HERE.